Cargando…
Proton pump inhibitor usage is associated with higher all-cause mortality and CV events in peritoneal dialysis patients
OBJECTIVES: A long period of inappropriate proton pump inhibitors (PPI) treatment has been proved to be associated with adverse prognosis in general population and hemodialysis patients. This study was conducted to clarify the impact of PPI usage on mortality and adverse cardiovascular (CV) events i...
Autores principales: | Zeng, Yingsi, Liu, Lingling, Zhu, Liya, Zhan, Xiaojiang, Peng, Fenfen, Feng, Xiaoran, Zhou, Qian, Zhang, Yujing, Wang, Zebin, Liang, Jianbo, Li, Jiao, Wen, Yueqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896194/ https://www.ncbi.nlm.nih.gov/pubmed/35236240 http://dx.doi.org/10.1080/0886022X.2022.2043903 |
Ejemplares similares
-
Proton pump inhibitor usage associates with higher risk of first episodes of pneumonia and peritonitis in peritoneal dialysis patients
por: Zhang, Yujing, et al.
Publicado: (2022) -
Neutrophil to Lymphocyte Ratio Predicts Adverse Cardiovascular Outcome in Peritoneal Dialysis Patients Younger than 60 Years Old
por: Zeng, Yingsi, et al.
Publicado: (2020) -
Hyperlipidemia and mortality in patients on peritoneal dialysis
por: Feng, Xiaoran, et al.
Publicado: (2022) -
Monocyte/Lymphocyte Ratio and Cardiovascular Disease Mortality in Peritoneal Dialysis Patients
por: Wen, Yueqiang, et al.
Publicado: (2020) -
Creatine Kinase and Mortality in Peritoneal Dialysis
por: Wu, Xianfeng, et al.
Publicado: (2022)